Outset Medical, Inc.

For the period ended Jun 30, 2026. Filed Aug 6, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Aug 6, 2026

OM$4.23+3.2%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Statements of Operations

(in thousands, except per share amounts)

Three Months Ended · Six Months Ended
	June 30,		June 30,
	2026	2025	2026	2025
Revenue:
Product revenue	$21,908	$23,082	$40,458	$44,376
Service and other revenue	9,727	8,337	19,040	16,795
Total revenue	31,635	31,419	59,498	61,171
Cost of revenue:
Cost of product revenue	11,799	11,791	20,632	22,793
Cost of service and other revenue	6,554	7,761	13,489	15,445
Total cost of revenue	18,353	19,552	34,121	38,238
Gross profit	13,282	11,867	25,377	22,933
Operating expenses:
Research and development	5,450	5,289	11,068	10,804
Sales and marketing	12,152	14,280	25,431	27,932
General and administrative	11,356	9,163	21,473	17,461
Total operating expenses	28,958	28,732	57,972	56,197
Loss from operations	(15,676)	(16,865)	(32,595)	(33,264)
Interest income and other income, net	1,354	1,903	2,881	3,879
Interest expense	(3,442)	(3,475)	(6,811)	(7,035)
Loss on extinguishment of term loan	—	—	—	(7,685)
Loss before provision for income taxes	(17,764)	(18,437)	(36,525)	(44,105)
Provision for income taxes	220	104	437	219
Net loss	$(17,984)	$(18,541)	$(36,962)	$(44,324)
Net loss per share, basic and diluted	$(0.97)	$(1.04)	$(2.00)	$(3.57)
Shares used in computing net loss per share, basic and diluted	18,619	17,743	18,496	12,420

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.